Precision-Driven
Diligence Technical Assessments
,

Ensuring accuracy, transparency, and
compliance.

Comprehensive Diligence & Mock Assessments

We offer a range of diligence and ‘mock’ assessments on on companies and assets within the Pharmaceutical, Biotech and Cell and Gene Therapy Space. This helps investors assess risks and value companies and assets more accurately, or prepare our clients for such assessments. Such diligence assessments can be tailed and scoped to the needs of the client, but incorporate the following aspects (as required): 

  • Licensing and compliance 

  • Quality Management Systems 

  • Personnel, resourcing and organisation structure 

  • Facilities, engineering and controls 

  • Site capabilities and capacity analysis

  • Site asset control and acquisition

  • Site financial running costs 

  • Remediation analysis and costing 

Do you need support or consultation?

Insights, Announcements & Events

Strengthening Quality Systems in a Rapidly Evolving Life Sciences Landscape

Why Risk Mitigation is Becoming a Top Priority in Pharma and Biotech

The Growing Importance
of Compliance Readiness in Cell & Gene Therapy

Quality System
Remediation: A Rising Need After Regulatory Findings

Strengthening Quality Systems in a Rapidly Evolving Life Sciences Landscape

Strengthening Quality Systems in a Rapidly Evolving Life Sciences Landscape

Helpful Answers to
Common Queries

Browse through our frequently asked questions to better understand how we work, what we offer, and how we can help your teams achieve quality and compliance goals.
What types of companies do you support within the life sciences sector?

We work with a wide range of life science organizations, including pharmaceutical manufacturers, biotechnology companies, and cell & gene therapy (CGT) developers. Our expertise also extends to contract development and manufacturing organizations (CDMOs), medical technology firms, and early-stage startups that need to establish strong quality foundations. Whether you are scaling operations, preparing for regulatory inspections, or remediating quality system gaps, we provide tailored support to meet your specific needs.

We work with a wide range of life science organizations, including pharmaceutical manufacturers, biotechnology companies, and cell & gene therapy (CGT) developers. Our expertise also extends to contract development and manufacturing organizations (CDMOs), medical technology firms, and early-stage startups that need to establish strong quality foundations. Whether you are scaling operations, preparing for regulatory inspections, or remediating quality system gaps, we provide tailored support to meet your specific needs.

We work with a wide range of life science organizations, including pharmaceutical manufacturers, biotechnology companies, and cell & gene therapy (CGT) developers. Our expertise also extends to contract development and manufacturing organizations (CDMOs), medical technology firms, and early-stage startups that need to establish strong quality foundations. Whether you are scaling operations, preparing for regulatory inspections, or remediating quality system gaps, we provide tailored support to meet your specific needs.

We work with a wide range of life science organizations, including pharmaceutical manufacturers, biotechnology companies, and cell & gene therapy (CGT) developers. Our expertise also extends to contract development and manufacturing organizations (CDMOs), medical technology firms, and early-stage startups that need to establish strong quality foundations. Whether you are scaling operations, preparing for regulatory inspections, or remediating quality system gaps, we provide tailored support to meet your specific needs.

We work with a wide range of life science organizations, including pharmaceutical manufacturers, biotechnology companies, and cell & gene therapy (CGT) developers. Our expertise also extends to contract development and manufacturing organizations (CDMOs), medical technology firms, and early-stage startups that need to establish strong quality foundations. Whether you are scaling operations, preparing for regulatory inspections, or remediating quality system gaps, we provide tailored support to meet your specific needs.

We work with a wide range of life science organizations, including pharmaceutical manufacturers, biotechnology companies, and cell & gene therapy (CGT) developers. Our expertise also extends to contract development and manufacturing organizations (CDMOs), medical technology firms, and early-stage startups that need to establish strong quality foundations. Whether you are scaling operations, preparing for regulatory inspections, or remediating quality system gaps, we provide tailored support to meet your specific needs.